Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
This study is ongoing, but not recruiting participants.
Sponsor:
University Hospitals of Cleveland
Collaborators:
AstraZeneca
Information provided by (Responsible Party):
Grace McComsey, University Hospitals of Cleveland
ClinicalTrials.gov Identifier:
NCT01218802
First received: October 8, 2010
Last updated: August 15, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |